CFDA just released on April 25, 2018, its Public Comment Draft of Pharmaceutical Data Exclusivity Implementing Rules (provisional) 药品试验数据保护实施办法（暂行）征求意见稿, available here (the web version is here). Comments are due by May 31, 2018, […]
Synergies and Contrasts Between The National IP Strategy Action Plan and Fourth Plenum (with contrasting wordclouds)
“”” Here is an unofficial translation of the English language translation of the Action plan of the National IP Strategy (2014 -2020) (NIPS), about which I previously blogged. A wordcloud from this English translation is above […]
Action Plan for Further Implementation of the National IP Strategy (2014-2020) Approved
According to a Chinese Government website, on December 29, the State Council reviewed and approved the Action Plan for Further Implementation of the National IP Strategy (2014-2020) (Action Plan). The Outline of the National […]
China’s Patent Domination?
Thomson Reuters just released a new report on China’s Innovation Quotient (Trends in Patenting and China’s Trends in Global Innovation). This is the fourth in a very useful multi-year series on Chinese […]
China IPR - Intellectual Property Developments in China 